National Ophthalmic Genotyping and Phenotyping Network (eyeGENE (Registered Trademark)), Stage 3 - Expansion of DNA and Data Repositories for Rare Inherited Ophthalmic Diseases | MicrobiomeTrials
National Ophthalmic Genotyping and Phenotyping Network (eyeGENE (Registered Trademark)), Stage 3 - Expansion of DNA and Data Repositories for Rare Inherited Ophthalmic Diseases
RecruitingOBSERVATIONAL
Trial Details
Start: 2024-07-12Est. Completion: 2054-06-27
Enrollment target: 1,000 participants
Locations
National Eye Institute (NEI), Bethesda, Maryland, United States
National Institutes of Health Clinical Center, Bethesda, Maryland, United States